[ Price : $8.95]
Santarus Inc. reports positive Phase 3 data in evaluating rifamycin SV MMX, indicated to treat travelers diarrhea.[ Price : $8.95]
Transcept Pharmaceuticals completes enrollment in a Phase 2 clinical trial evaluating TO-2061 (ondansetron) as adjunctive therapy ...[ Price : $8.95]
A new study finds that mild-to-moderate asthma sufferers using a low-dose inhaled corticosteroid daily fared no better than those ...[ Price : $8.95]
Stakeholders at an FDA public meeting on Strengthening the National Medical Device Postmarket Surveillance System caution that bui...[ Price : $8.95]
A CDER official describes the development and purpose of an evolving benefit-risk framework to be used internally by review staff ...[ Price : $8.95]
FDA tells science writers that the past two years have brought a dramatic increase in the agencys ability to respond to public hea...[ Price : $8.95]
FDA and Cold Genesys reach agreement on a special protocol assessment for a Phase 2/3 trial of the companys CG0070 for non-muscle ...[ Price : $8.95]
FDAs Atlanta District Office warns Kimberly-Clerk about Medical Device Reporting violations at its Roswell, GA, manufacturing faci...